关注
Raghuraj Singh
Raghuraj Singh
Academy of Scientific and Innovative Research-Institute of Nano Science and Technology (AcSIR-INST)
在 inst.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy
K Vaghasiya, E Ray, R Singh, K Jadhav, A Sharma, R Khan, OP Katare, ...
Materials Science and Engineering: C 123, 112027, 2021
642021
Fat fighting liraglutide based nano-formulation to reverse obesity: design, development and animal trials
DK Jakhar, VK Vishwakarma, R Singh, K Jadhav, S Shah, T Arora, ...
International Journal of Pharmaceutics 634, 122585, 2023
102023
Systematic development and optimization of spray-dried Quercetin-HP-β-cyclodextrin microparticles for DPI-based therapy of lung cancer
K Vaghasiya, E Ray, A Sharma, R Singh, K Jadhav, R Khan, OP Katare, ...
Journal of Materials Science 56 (26), 14700-14716, 2021
92021
Nanophytomedicine market: global opportunity analysis and industry forecast
R Shukla, K Thok, I Alam, R Singh
Nanophytomedicine: Concept to Clinic, 19-31, 2020
92020
Taming the devil: antimicrobial peptides for safer TB therapeutics
K Jadhav, R Singh, E Ray, AK Singh, RK Verma
Current Protein and Peptide Science 23 (10), 643-656, 2022
82022
Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation
K Jadhav, A Jhilta, R Singh, E Ray, N Sharma, R Shukla, AK Singh, ...
Biomaterials Advances 154, 213594, 2023
72023
New generation smart drug delivery systems for rheumatoid arthritis
R Singh, K Jadhav, K Vaghasiya, E Ray, R Shukla, RK Verma
Current Pharmaceutical Design 29 (13), 984-1001, 2023
62023
Self-actuating inflammation responsive hydrogel microsphere formulation for controlled drug release in rheumatoid arthritis (RA): Animal trials and study in human fibroblast …
R Singh, K Jadhav, R Kamboj, H Malhotra, E Ray, A Jhilta, V Dhir, ...
Biomaterials Advances 160, 213853, 2024
32024
Neurodegenerative disorders due to inhalation of various small particles
RKV Krishna Jadhav, Raghuraj Singh, Eupa Ray, Kalpesh Vaghasiya
Nanomedical Drug Delivery for Neurodegenerative Diseases, 41-54, 2022
32022
Nanomedical Drug Delivery for Neurodegenerative Diseases
SJSF Awesh K Yadav, Rahul Shukla
Academic Press, 2022
2*2022
Recent Developments in Tyrosine Kinase Inhibitor-based Nanotherapeutics for EGFR-resistant Non-small Cell Lung Cancer.
E Kole, K Jadhav, R Singh, S Mandpe, A Abhang, RK Verma, J Naik
Current Drug Delivery, 2024
12024
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
R Singh, A Panghal, K Jadhav, A Thakur, RK Verma, C Singh, M Goyal, ...
Molecular Neurobiology, 1-25, 2024
2024
A critical review on developments in drying technologies for enhanced stability and bioavailability of pharmaceuticals
K Jadhav, E Kole, R Singh, SK Rout, RK Verma, A Chatterjee, ...
Drying Technology, 1-27, 2024
2024
Targeted delivery of metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid Nano-assemblies
E Ray, K Jadhav, M Kadian, G Sharma, K Sharma, A Jhilta, R Singh, ...
2024
Application of nanoemulsion in pharmaceuticals industry
K Jadhav, R Singh, E Ray, RK Verma
Industrial Applications of Nanoemulsion, 107-156, 2024
2024
Basics of Flavors and the Significance of the Flavor Industry in Relation to Nutraceuticals and Functional Foods
R Singh, K Yadav, D Yadav
Flavor Development for Functional Foods and Nutraceuticals, 21-37, 2019
2019
PREPARATION AND EVALUATION OF DIETHYLCARBAMAZINE CITRATE LOADED NANOSTRUCTURED LIPID CARRIERS FOR ORAL LYMPHATIC DELIVERY
R SHUKLA, R SINGH
2019
系统目前无法执行此操作,请稍后再试。
文章 1–17